Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial

BACKGROUND: Dual bronchodilation combining a long-acting β(2)-agonist (LABA) and a long-acting muscarinic antagonist (LAMA) is the preferred choice of treatment recommended by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 guidelines for the management of patients with modera...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogelmeier, Claus F., Gaga, Mina, Aalamian-Mattheis, Maryam, Greulich, Timm, Marin, Jose M., Castellani, Walter, Ninane, Vincent, Lane, Stephen, Nunez, Xavier, Patalano, Francesco, Clemens, Andreas, Kostikas, Konstantinos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516383/
https://www.ncbi.nlm.nih.gov/pubmed/28720132
http://dx.doi.org/10.1186/s12931-017-0622-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516383/
https://www.ncbi.nlm.nih.gov/pubmed/28720132
http://dx.doi.org/10.1186/s12931-017-0622-x

Ejemplares similares